Department of Infectious Diseases, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Department of Infectious Diseases, Fujita Health University School of Medicine, Toyoake, Aichi, Japan
J Clin Microbiol. 2018 Aug 27;56(9). doi: 10.1128/JCM.00959-18. Print 2018 Sep.
Hypervirulent strains have higher potential to cause more severe and disseminated infections than classic strains. While initially reported from East Asian countries, cases have now been identified worldwide, sometimes in conjunction with extensive drug resistance. In this issue of the , T. A. Russo et al. (J Clin Microbiol 56:e00776-18, 2018, https://doi.org/10.1128/JCM.00776-18) validated the diagnostic accuracy of biomarkers that differentiate hypervirulent strains from classic strains. This represents a major step forward in building a consensus definition and designing international studies aimed at elucidating the global epidemiology, clinical features, and outcome of this important pathogen.
高毒力菌株比经典菌株更有可能导致更严重和更广泛的感染。虽然最初报道于东亚国家,但现在已在全球范围内发现了此类病例,有时还伴有广泛的耐药性。在本期的《临床微生物学杂志》中,T. A. 鲁索等人(J Clin Microbiol 56:e00776-18, 2018, https://doi.org/10.1128/JCM.00776-18)验证了区分高毒力和经典菌株的生物标志物的诊断准确性。这是朝着建立共识定义和设计旨在阐明这一重要病原体的全球流行病学、临床特征和结局的国际研究迈出的重要一步。